Zephyrnet Logo

Tag: expressly

US ADP national employment 184k versus expectations of 148k | Forexlive

High risk warning: Foreign exchange trading carries a...

US March ADP employment +184K vs +148K expected | Forexlive

High risk warning: Foreign exchange trading carries a...

Imperial Brands Takes 19.8% Stake in Auxly

TORONTO – Auxly Cannabis Group Inc., a leading consumer packaged goods company in the cannabis products market, completed the conversion of $123.4 million of principal and...

Delhi HC in Sulphur Mills Limited v. Dharmaj Crop Guard Limited & Ors.– Case of Credible Challenge to the Validity of the Patent

Recently, the Delhi High Court rejected Sulphur Mills’ request for an interim injunction against Dharmaraj Corp Guard, finding their patent on a sulphur-based agrochemical...

CMS and Incyte Announce Collaboration and License Agreement for Povorcitinib in China and Southeast Asia

HONG KONG, China and WILMINGTON, Del., Apr 1, 2024 - (ACN Newswire) - China Medical System Holdings Limited (“CMS” or the “Group”) and Incyte (Nasdaq:INCY)...

9 beauty products that can give your Warhammer 40K minis a makeover

Sometimes, I do my nails. Sometimes, I paint my minis. And sometimes, I paint my minis while doing my nails. The disciplines of nail...

IM Cannabis Reports 2023 Financial Results

TORONTO and GLIL YAM, Israel — IM Cannabis Corp., an international medical cannabis company, announced its financial and operational results for the year ended December 31,...

Lead Generation: A Beginner’s Guide to Generating Business Leads the Inbound Way

Have you ever noticed that telemarketers have a way of calling at the worst possible time? Say, right when you’re about to sit down...

USD/JPY update – lower (in a small range) after Suzuki’s verbal intervention | Forexlive

High risk warning: Foreign exchange trading carries a...

Sequana Medical announces 2023 Full Year Results and 2024 Outlook | BioSpace

PRESS RELEASEREGULATED INFORMATION – INSIDE INFORMATION28 March 2024, 08:00 a.m. CET alfapump® – PMA1 submitted to US FDA and accepted for substantive review, extensive feedback...

Vivos Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Operational Update | BioSpace

Positive Business Momentum and Sales Pipeline Growth Following FDA 510(k) Clearance of Vivos’ Proprietary Oral Medical Devices to Treat Severe Obstructive Sleep Apnea Annual Operating...

Latest Intelligence

spot_img
spot_img